HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.

Abstract
All types of amyloidosis are structurally characterized by the cross beta-pleated sheet conformation of the fibrils, irrespective of their biochemical composition. The clinical observation that the anthracycline 4'-iodo-4'-deoxy-doxorubicin (IDOX) can induce amyloid resorption in patients with immunoglobulin light chain amyloidosis was the starting point for this investigation of its possible mechanism of action. IDOX binds strongly to all five types of natural amyloid fibrils tested: immunoglobulin light chains, amyloid A, transthyretin (methionine-30 variant), beta-protein (Alzheimer), and beta 2-microglobulin. Quantitative binding studies showed that IDOX, but not doxorubicin, binds strongly to amyloid fibrils. This binding is saturable and involves two apparently distinct binding sites with Kd values of 5.9 x 10(-11) M and 3.4 x 10(-9) M. IDOX inhibited in vitro insulin amyloid fibrillogenesis. In vivo studies using the experimental amyloid murine model confirmed the specific targeting of IDOX to amyloid deposits. Preincubation of amyloid enhancing factor with IDOX significantly reduced the formation of amyloid deposits. It is hypothesized that IDOX exerts its beneficial effects through the inhibition of fibril growth, thus increasing the solubility of existing amyloid deposits and facilitating their clearance. IDOX may represent the progenitor of a class of amyloid-binding agents that could have both diagnostic and therapeutic potential in all types of amyloidoses.
AuthorsG Merlini, E Ascari, N Amboldi, V Bellotti, E Arbustini, V Perfetti, M Ferrari, I Zorzoli, M G Marinone, P Garini
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 92 Issue 7 Pg. 2959-63 (Mar 28 1995) ISSN: 0027-8424 [Print] United States
PMID7708755 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid
  • Glycoproteins
  • Immunoglobulin Light Chains
  • Insulin
  • Prealbumin
  • Serum Amyloid A Protein
  • amyloid enhancing factor
  • 4'-deoxy-4'-iododoxorubicin
  • Doxorubicin
Topics
  • Amyloid (chemistry, drug effects, metabolism)
  • Amyloidosis (prevention & control)
  • Animals
  • Doxorubicin (analogs & derivatives, metabolism, pharmacology, therapeutic use)
  • Female
  • Glycoproteins
  • Immunoglobulin Light Chains (chemistry, drug effects, metabolism)
  • Insulin (chemistry, metabolism)
  • Mice
  • Mice, Inbred Strains
  • Prealbumin (chemistry, drug effects, metabolism)
  • Protein Structure, Secondary
  • Serum Amyloid A Protein (analysis)
  • Spleen (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: